Predictors of early safety outcomes with axicabtagene ciloleucel (axi-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL) Meeting Abstract


Authors: Strouse, C.; Farooq, U.; Shouval, R.; Vallurupalli, A.; Moskop, A.; Jacobson, C. A.; Locke, F.; Baird, J. H.; Strati, P.; Patel, D. A.; Dahiya, S.; Hemmer, M. T.; Du, B.; Spooner, C.; Kim, J. J.; Mirjah, D. L.; Hu, Z. H.; Pasquini, M. C.; Lin, Y.
Abstract Title: Predictors of early safety outcomes with axicabtagene ciloleucel (axi-cel) in patients with relapsed or refractory (R/R) large B-cell lymphoma (LBCL)
Meeting Title: 66th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 144
Issue: Suppl. 1
Meeting Dates: 2024 Dec 7-10
Meeting Location: San Diego, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2024-11-05
Start Page: 609
End Page: 610
Language: English
ACCESSION: WOS:001412638600009
DOI: 10.1182/blood-2024-207976
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Roni Shouval
    171 Shouval